Interestingly, we did not observe any appreciable changes in the receptor expression in the CD19+ B-cell subsets of ALL subjects both at diagnosis and at the end of induction chemotherapy as compared to healthy subjects. Here, CD19 is linked to acute lymphoblastic leukemia.